Foster & Motley’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
8,704
-629
-7% -$116K 0.07% 186
2026
Q1
$1.76M Buy
9,333
+118
+1% +$24.9K 0.09% 180
2025
Q4
$1.83M Buy
9,215
+756
+9% +$153K 0.1% 169
2025
Q3
$1.72M Sell
8,459
-430
-5% -$76.3K 0.09% 183
2025
Q2
$1.56M Buy
8,889
+4,181
+89% +$629K 0.09% 192
2025
Q1
$633K Buy
4,708
+1,229
+35% +$162K 0.04% 259
2024
Q4
$439K Hold
3,479
– – 0.03% 289
2024
Q3
$578K Sell
3,479
-292
-8% -$44.2K 0.04% 260
2024
Q2
$502K Buy
3,771
+195
+5% +$23.5K 0.03% 266
2024
Q1
$376K Buy
+3,576
New +$321K 0.03% 291

Other funds holding THC

Foster & Motley's THC Position: Q2 2026 in Review

Foster & Motley reduced its Tenet Healthcare (THC) stake by 6.7% in Q2 2026, selling an estimated $116K and leaving 8,704 shares worth $1.63M. The position accounts for 0.07% of the portfolio, ranked #186.

Foster & Motley first reported a position in THC in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.83M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Foster & Motley held 8,704 shares of Tenet Healthcare worth $1.63M as of Q2 2026.
  • Foster & Motley sold 629 Tenet Healthcare shares in Q2 2026, an estimated $116K.
  • Tenet Healthcare made up 0.07% of Foster & Motley's portfolio in Q2 2026, its #186 holding.
  • Foster & Motley first reported a position in Tenet Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Foster & Motley's Tenet Healthcare position peaked at $1.83M in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Foster & Motley's 13F filing for Q2 2026, filed 7 Aug 2026.